Posted by Michael Wonder on 24 Feb 2023
Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reforms
23 February 2023 - A member of the Patented Medicine Prices Review Board, Canada’s drug pricing regulator, has resigned over what he calls a “lack of support” from the federal government and failure to implement “critically important” reforms to lower the cost of medicine.
In a letter addressed to federal Health Minister Jean-Yves Duclos, Matthew Herder said it has been a “privilege” to serve as a member of the PMPRB since 2018, but said he must “regretfully resign.”
